Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience
Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience
Specialist pharmaceutical experience strengthens Symbiosis’ international growth ambitions
Virginie Cavalli appointed Chief Executive Officer of Seppic
Virginie Cavalli appointed Chief Executive Officer of Seppic
Seppic announces the appointment of Virginie Cavalli as Chief Executive Officer, effective September 1, 2026
Uwe Röhrhoff steps down as Interim CEO of Gerresheimer AG
Uwe Röhrhoff steps down as Interim CEO of Gerresheimer AG
Wolf Lehmann, CFO, and Achim Schalk, Member of the Management Board, will assume his duties until further notice
Symbiosis strengthens commercial team with appointment of Jay Chima
Symbiosis strengthens commercial team with appointment of Jay Chima
Symbiosis appoints Jay Chima as vice president, business development, to support growth and strengthen partnerships across the pharmaceutical and biotechnology sectors
Lonza appoints Samanta Cimitan as chief commercial officer
Lonza appoints Samanta Cimitan as chief commercial officer
Newly created role will strengthen customer engagement, commercial delivery and a harmonised go-to-market approach across One Lonza
Piramal Pharma completes acquisition of controlling stake in Yapan Bio
Piramal Pharma completes acquisition of controlling stake in Yapan Bio
Acquisition strengthens Piramal’s biologics capabilities and integrated large molecule CDMO offering
Anders Fogelberg appointed president and CEO of BICO Group AB
Anders Fogelberg appointed president and CEO of BICO Group AB
BICO appoints current Chief Commercial Officer Anders Fogelberg as President and CEO, effective September 1, 2026
Pace appoints Andy Fenny as President of Pace Life Sciences
Pace appoints Andy Fenny as President of Pace Life Sciences
Experienced life sciences executive brings more than 20 years of CDMO and pharmaceutical leadership to drive strategic growth
Clinilabs announces leadership expansion
Clinilabs announces leadership expansion
Laura Shannon joins the organisation as Chief Executive Officer while Gary Zammit, the Company’s founder, assumes the role of Executive Chairperson
As new CTO, Christian Reichardt is driving the technological advancement of Optima Pharma
As new CTO, Christian Reichardt is driving the technological advancement of Optima Pharma
This investment is driven by growth areas such as biologics, GLP-1 products, and other sterile pharmaceuticals, as well as the increasing demand for isolator and high-potency...
Reacta Healthcare appoints Iedena Lima as head of research and development
Reacta Healthcare appoints Iedena Lima as head of research and development
Extensive pharma and medtech sector experience strengthens senior leadership to support growth and strategic expansion
Clinilabs announces medical leadership appointments
Clinilabs announces medical leadership appointments
Bob Dagher, M.D., named chief medical officer and Waqar Ahmed Siddiqui, M.D., named principal investigator
FUJIFILM Biotechnologies transitions leadership to drive next phase of operational excellence
FUJIFILM Biotechnologies transitions leadership to drive next phase of operational excellence
FUJIFILM Biotechnologies today announced a planned leadership evolution as the Company enters its next phase of execution and sustainable growth
Fresenius Medical Care appoints Cassie McLean as Management Board member for Care Delivery
Fresenius Medical Care appoints Cassie McLean as Management Board member for Care Delivery
Cassie McLean succeeds Craig Cordola as CEO of Care Delivery, effective 1 August 2026
IMCD appoints Vlad Miller as president, US
IMCD appoints Vlad Miller as president, US
Vlad Miller takes on the role of President, US, following five months leading the business on an interim basis
Actimed strengthens board with appointment of Dr Anders Ullman
Actimed strengthens board with appointment of Dr Anders Ullman
Pharmaceutical executive brings more than 30 years of international drug development and corporate leadership experience
Previous
1
(current)
2
3
4
5
6
7
…
215
Next
Trending Articles
DFE Pharma appoints Khatera Alawi as new Global Director Human Resources
An experienced international HR leader, Alawi joins DFE Pharma’s Leadership Team to support the company’s people-centric, high-performance culture
Lonza appoints Samanta Cimitan as chief commercial officer
Newly created role will strengthen customer engagement, commercial delivery and a harmonised go-to-market approach across One Lonza
Pace appoints Andy Fenny as President of Pace Life Sciences
Experienced life sciences executive brings more than 20 years of CDMO and pharmaceutical leadership to drive strategic growth
Virginie Cavalli appointed Chief Executive Officer of Seppic
Seppic announces the appointment of Virginie Cavalli as Chief Executive Officer, effective September 1, 2026
Uwe Röhrhoff steps down as Interim CEO of Gerresheimer AG
Wolf Lehmann, CFO, and Achim Schalk, Member of the Management Board, will assume his duties until further notice
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all